drugset / Trial / NCT06650930

Pharmacokinetics of Oral Calcium Carbonate in Parturients

NCT06650930

Phase 0 Not yet recruiting 60 enrolled Stanford University
NaSingle-groupOpen-labelOther

Summary

This study investigates the time course of change in calcium in the blood after a pregnant subject takes an oral dose of calcium carbonate (commonly marketed as "Tums"). This information is important for trials investigating whether calcium can reduce postpartum hemorrhage, bleeding after delivery.

Timeline

Start
2025-01
Primary completion
2025-08
Completion
2025-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcium carbonate Other / unclassified 3000 mg Oral

Indications